Efficacy of Simethicone in Preparation Prior to Upper Gastrointestinal En-doscopy

Document Type : Original Article (s)

Authors

1 Medical Students Research committee, Isfahan University of Medical Sciences and Poursina Hakim Research Institute, Isfahan, Iran.

2 Medical Students Research committee, Isfahan University of Medical Sciences, Isfahan, Iran.

3 Associate Professor, Department of Gastroenterology, Isfahan University of Medical Sciences and Poursina Hakim Research Institute, Isfahan, Iran.

Abstract

Background: The presence of foam/bubbles in stomach and duodenum is a common problem during esophagogastroduodenoscopy (EGD) that interferes with precise evaluation of the mucosa. We evaluated the effectiveness of simethicone in reducing foam/bubbles in stomach and duodenum, endoscopy duration, and patient satisfaction.Methods: This double-blind, randomized, placebo-controlled trial was conducted on candidates for elective EGD referring to Poursina Hakim Clinic, Isfahan (Iran). Participants received 40 mg chewable tablet of simethicone or placebo, with 30 ml water, 15-30 minutes before the EGD. Foam/bubbles during endoscopy were assessed and graded by a single endoscopist from 0 to 3 and the endoscopy duration was recorded. Patient’s satisfaction was scored from 0 to 10.Finding: During the study, 90 and 83 patients were entered into the simethicone and placebo groups, respectively. Degree of foam/bubbles was significantly less in simethicone compared to placebo group (P = 0.002). No difference was found between the two groups in foam/bubbles of duodenum (P > 0.05). Duration of endoscopy was, on average, one minute shorter in simethicone compared with placebo group (P < 0.001). Patient’s satisfaction was similar between the two groups. No adverse effect was observed from simethicone.Conclusion: Simethicone before EGD significantly reduce the foam/bubbles in stomach and provide better visibility for evaluating the mucosa, and also decrease the duration of endoscopy. Accordingly, routine administration of simethicone for preparation before EGD is recommended.    

Keywords

References

  1. Cohen J, Safdi MA, Deal SE, Baron TH, Chak A, Hoffman B, et al. Quality indicators for esoph-agogastroduodenoscopy. Am J Gastroenterol 2006; 101(4): 886-91.
  2. Kwan V, Deviere J. Endoscopy essentials: prepa-ration, sedation, and surveillance. Endoscopy 2008; 40(1): 65-70.
  3. Enns R. Capsule endoscopy: in search of the ideal image. Am J Gastroenterol 2008; 103(1): 83-5.
  4. Lewis BS, Swain P. Capsule endoscopy in the evaluation of patients with suspected small in-testinal bleeding: results of a pilot study. Gastro-intest Endosc 2002; 56(:349-353.
  5. Brecevic L, Bosan-Kilibarda I, Strajnar F. Mechanism of antifoaming action of simethi-cone. J Appl Toxicol 1994; 14(3): 207-11.
  6. Holtmann G, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of sime-thicone and cisapride for the treatment of pa-tients with functional dyspepsia. Aliment Phar-macol Ther 2002; 16(9):1641-8.
  7. Wu L, Cao Y, Liao C, Huang J, Gao F. System-atic review and meta-analysis of randomized controlled trials of Simethicone for gastrointesti-nal endoscopic visibility. Scand J Gastroenterol 2010.
  8. Sudduth RH, DeAngelis S, Sherman KE, McNal-ly PR. The effectiveness of simethicone in im-proving visibility during colonoscopy when given with a sodium phosphate solution: a double-bind randomized study. Gastrointest Endosc 1995; 42(5): 413-5.
  9. Saghaei M. Random allocation software for parallel group randomized trials. BMC Med Res Methodol 2004; 4: 26.
  10. Banerjee B, Parker J, Waits W, Davis B. Effec-tiveness of preprocedure simethicone drink in improving visibility during esophagogastroduo-denoscopy: a double-blind, randomized study. J Clin Gastroenterol 1992; 15(3): 264-5.
  11. Bertoni G, Gumina C, Conigliaro R, Ricci E, Staffetti J, Mortilla MG, et al. Randomized pla-cebo-controlled trial of oral liquid simethicone prior to upper gastrointestinal endoscopy. En-doscopy 1992; 24(4): 268-70.
  12. Keeratichananont S, Sobhonslidsuk A, Kitiyakara T, Achalanan N, Soonthornpun S. The role of liquid simethicone in enhancing en-doscopic visibility prior to esophagogastroduo-denoscopy (EGD): A prospective, randomized, double-blinded, placebo-controlled trial. J Med Assoc Thai 2010; 93(8): 892-7.
Journal of Isfahan Medical School
Volume 29, Issue 127 - Serial Number 127
January and February 2011
Pages 95-101

Files

History

  • Receive Date: 13 February 2011
  • Revise Date: 02 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics